Johnson & Johnson price target raised to $166 from $159 at Barclays
Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company ...
Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says
HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...